Oncogenic EGFR and PDGFR signalling mechanisms are important contributors to tumour growth and invasion in GBM, and NF-κB is implicated in at least some of the tumour promoting functions of these receptors [31,32,33,34,35]. The gene discussed is EGFR; the disease is neoplasm.